Rituximab for childhood-onset nephrotic syndrome

The Lancet

Volume 384, Issue 9950, 4–10 October 2014, Pages 1242-1243

P Ravani et al.
Rituximab is a safe and effective long-term treatment for children with steroid and calcineurin inhibitor-dependent idiopathic nephrotic syndrome
Kidney Int
(2013)
KR Carson et al.
Progressive multifocal leukoencephalopathy after rituximab therapy in HIV-negative patients: a report of 57 cases from the Research on Adverse Drug Events and Reports project
Blood
(2009)
RM Lombel et al.
Treatment of steroid-sensitive nephrotic syndrome: new guidelines from KDIGO
Pediatr Nephrol
(2013)
Y Hamasaki et al.
Cyclosporine and steroid therapy in children with steroid-resistant nephrotic syndrome
Pediatr Nephrol
(2009)
N Pravitsitthikul et al.
Non-corticosteroid immunosuppressive medications for steroid-sensitive nephrotic syndrome in children
Cochrane Database Syst Rev
(2013)
MJ Kemper et al.
Long-term follow-up after rituximab for steroid-dependent idiopathic nephrotic syndrome
Nephrol Dial Transplant
(2012)
S Tellier et al.
Long-term outcome of children treated with rituximab for idiopathic nephrotic syndrome
Pediatr Nephrol
(2013)

There are more references available in the full text version of this article.